- Home
- PAC vs HOLX Comparison
PAC vs HOLX Comparison
Compare PAC & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PAC | HOLX |
|---|---|---|
| Founded | 1998 | 1985 |
| Country | Mexico | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Medical Electronics |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7B | 16.6B |
| IPO Year | 2006 | 1990 |
Fundamental Metrics
Financial Performance| Metric | PAC | HOLX |
|---|---|---|
| Price | $228.18 | $74.98 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 15 |
| Target Price | ★ $210.00 | $79.64 |
| AVG Volume (30 Days) | 89.5K | ★ 3.0M |
| Earning Date | 10-20-2025 | 11-03-2025 |
| Dividend Yield | ★ 4.95% | N/A |
| EPS Growth | ★ 13.32 | N/A |
| EPS | 1.07 | ★ 2.49 |
| Revenue | $1,870,491,921.00 | ★ $4,100,500,000.00 |
| Revenue This Year | $56.92 | $6.69 |
| Revenue Next Year | $8.83 | $5.74 |
| P/E Ratio | ★ $21.24 | $30.11 |
| Revenue Growth | ★ 35.46 | 1.74 |
| 52 Week Low | $168.62 | $51.90 |
| 52 Week High | $259.33 | $80.31 |
Technical Indicators
Market Signals| Indicator | PAC | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 51.89 | 67.93 |
| Support Level | $230.55 | $74.55 |
| Resistance Level | $240.39 | $75.12 |
| Average True Range (ATR) | 5.28 | 0.28 |
| MACD | 0.54 | -0.14 |
| Stochastic Oscillator | 43.80 | 78.92 |
Price Performance
Historical ComparisonAbout PAC Grupo Aeroportuario Del Pacifico
Grupo Aeroportuario del Pacifico SAB de CV is engaged in the construction, development, and operation of airports in Mexico. The company's segment includes Guadalajara; Tijuana; Puerto Vallarta; San Jose del Cabo; Montego Bay; Hermosillo; Guanajuato and Other Airports. It generates maximum revenue from the Guadalajara segment.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.